64 related articles for article (PubMed ID: 1776860)
1. Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.
Mazzoni A; Trave F; Fabbri M; Leto G; Ghidoni R
Anticancer Res; 1991; 11(6):2181-5. PubMed ID: 1776860
[TBL] [Abstract][Full Text] [Related]
2. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells.
Mazzoni A; Trave F
Oncol Res; 1993; 5(2):75-82. PubMed ID: 8364256
[TBL] [Abstract][Full Text] [Related]
4. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of multidrug-resistant human T-lymphoblastoid CEM cell line to cell-mediated cytolysis.
Ramoni C; Dupuis ML; Cenciarelli C; Ciccolini F; Cianfriglia M
Ann Ist Super Sanita; 1990; 26(3-4):433-9. PubMed ID: 1982604
[TBL] [Abstract][Full Text] [Related]
6. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells.
Kimmig A; Gekeler V; Neumann M; Frese G; Handgretinger R; Kardos G; Diddens H; Niethammer D
Cancer Res; 1990 Nov; 50(21):6793-9. PubMed ID: 1698543
[TBL] [Abstract][Full Text] [Related]
8. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods.
Yang LY; Trujillo JM
Cancer Res; 1990 Jun; 50(11):3218-25. PubMed ID: 2334917
[TBL] [Abstract][Full Text] [Related]
9. Effect of the tiapamil analog RO11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells.
Mazzoni A; Trave F; Canti G; Franco P
Anticancer Res; 1989; 9(2):367-71. PubMed ID: 2751261
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
11. Cell surface phenotype and increased penetration of human multidrug-resistant ovarian carcinoma cells into in vitro collagen-fibroblasts matrix.
Sedlák J; Sedláková O; Hlavcák P; Hunáková L; Bízik J; Grófová M; Chorváth B
Neoplasma; 1996; 43(6):389-95. PubMed ID: 8996563
[TBL] [Abstract][Full Text] [Related]
12. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
Safrit JT; Berek JS; Bonavida B
Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
[TBL] [Abstract][Full Text] [Related]
14. A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells.
Herweijer H; van den Engh G; Nooter K
Cytometry; 1989 Jul; 10(4):463-8. PubMed ID: 2766891
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of adriamycin-resistant human ovarian carcinoma cell line and its mechanism of multidrug resistance].
Li PY; Lin C
Yao Xue Xue Bao; 1995; 30(4):258-62. PubMed ID: 7660793
[TBL] [Abstract][Full Text] [Related]
16. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes.
Gambacorti-Passerini C; Rivoltini L; Supino R; Rodolfo M; Radrizzani M; Fossati G; Parmiani G
Cancer Res; 1988 May; 48(9):2372-6. PubMed ID: 3258541
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of the complementary DNA for the M(r) 85,000 protein overexpressed in adriamycin-resistant human tumor cells.
Sugimoto Y; Hamada H; Tsukahara S; Noguchi K; Yamaguchi K; Sato M; Tsuruo T
Cancer Res; 1993 Jun; 53(11):2538-43. PubMed ID: 8495417
[TBL] [Abstract][Full Text] [Related]
20. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
Harel W; Shau H; Hadley CG; Morgan AC; Reisfeld RA; Cheresh DA; Mitchell MS
Cancer Res; 1990 Oct; 50(19):6311-5. PubMed ID: 2400994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]